Promising preliminary results from a trial of the Alzheimer’s drug donanemab, first announced in May, have now been confirmed.

The post “Another milestone” – successful phase 3 trial of Alzheimer’s drug, donanemab, confirmed  appeared first on Alzheimer's Research UK.